TLV: REKA Statistics
Total Valuation
Rekah Pharmaceutical Industry has a market cap or net worth of ILS 153.87 million. The enterprise value is 297.61 million.
Market Cap | 153.87M |
Enterprise Value | 297.61M |
Important Dates
The last earnings date was Tuesday, November 26, 2024.
Earnings Date | Nov 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Rekah Pharmaceutical Industry has 11.41 million shares outstanding. The number of shares has increased by 9.50% in one year.
Current Share Class | n/a |
Shares Outstanding | 11.41M |
Shares Change (YoY) | +9.50% |
Shares Change (QoQ) | +4.85% |
Owned by Insiders (%) | 40.54% |
Owned by Institutions (%) | 2.78% |
Float | 1.87M |
Valuation Ratios
The trailing PE ratio is 19.97.
PE Ratio | 19.97 |
Forward PE | n/a |
PS Ratio | 0.46 |
PB Ratio | 0.94 |
P/TBV Ratio | 1.51 |
P/FCF Ratio | 11.62 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.11, with an EV/FCF ratio of 22.47.
EV / Earnings | 39.03 |
EV / Sales | 0.90 |
EV / EBITDA | 6.11 |
EV / EBIT | 18.41 |
EV / FCF | 22.47 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.90.
Current Ratio | 1.43 |
Quick Ratio | 0.89 |
Debt / Equity | 0.90 |
Debt / EBITDA | 3.03 |
Debt / FCF | 11.13 |
Interest Coverage | 2.24 |
Financial Efficiency
Return on equity (ROE) is 4.75% and return on invested capital (ROIC) is 3.09%.
Return on Equity (ROE) | 4.75% |
Return on Assets (ROA) | 2.18% |
Return on Capital (ROIC) | 3.09% |
Revenue Per Employee | 776,571 |
Profits Per Employee | 17,857 |
Employee Count | 427 |
Asset Turnover | 0.72 |
Inventory Turnover | 2.90 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.32% in the last 52 weeks. The beta is 0.04, so Rekah Pharmaceutical Industry's price volatility has been lower than the market average.
Beta (5Y) | 0.04 |
52-Week Price Change | -9.32% |
50-Day Moving Average | 1,399.02 |
200-Day Moving Average | 1,394.04 |
Relative Strength Index (RSI) | 47.91 |
Average Volume (20 Days) | 1,569 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rekah Pharmaceutical Industry had revenue of ILS 331.60 million and earned 7.63 million in profits. Earnings per share was 0.68.
Revenue | 331.60M |
Gross Profit | 72.74M |
Operating Income | 16.11M |
Pretax Income | 7.62M |
Net Income | 7.63M |
EBITDA | 41.92M |
EBIT | 16.11M |
Earnings Per Share (EPS) | 0.68 |
Balance Sheet
The company has 3.72 million in cash and 147.41 million in debt, giving a net cash position of -143.69 million or -12.59 per share.
Cash & Cash Equivalents | 3.72M |
Total Debt | 147.41M |
Net Cash | -143.69M |
Net Cash Per Share | -12.59 |
Equity (Book Value) | 164.37M |
Book Value Per Share | 14.40 |
Working Capital | 69.51M |
Cash Flow
In the last 12 months, operating cash flow was 23.62 million and capital expenditures -10.37 million, giving a free cash flow of 13.25 million.
Operating Cash Flow | 23.62M |
Capital Expenditures | -10.37M |
Free Cash Flow | 13.25M |
FCF Per Share | 1.16 |
Margins
Gross margin is 21.94%, with operating and profit margins of 4.86% and 2.30%.
Gross Margin | 21.94% |
Operating Margin | 4.86% |
Pretax Margin | 2.30% |
Profit Margin | 2.30% |
EBITDA Margin | 12.64% |
EBIT Margin | 4.86% |
FCF Margin | 3.99% |
Dividends & Yields
Rekah Pharmaceutical Industry does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.50% |
Shareholder Yield | -9.50% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Rekah Pharmaceutical Industry has an Altman Z-Score of 1.44. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.44 |
Piotroski F-Score | n/a |